Predicted Trait | |
Reported Trait | HbA1c |
Mapped Trait(s) | HbA1c measurement (EFO_0004541) |
Additional Trait Information | Score composed of glycemic variants associated with HbA1c, used to predict diabetes incidence |
Score Construction | |
PGS Name | GS-G-AFR |
Development Method | |
Name | GWAS |
Parameters | Study-wide multi-ancestry GWAS significant SNPs |
Variants | |
Original Genome Build | NCBI36 |
Number of Variants | 19 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000064 |
Citation (link to publication) | Wheeler E et al. PLoS Med (2017) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | African: 100% 7,564 individuals (100%) |
PGS Evaluation | African: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST007952 Europe PMC: 28898252 |
7,564 individuals | African American or Afro-Caribbean | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM000411 | PSS000234| African Ancestry| 1,906 individuals |
PGP000064 | Wheeler E et al. PLoS Med (2017) |
Reported Trait: Incident type 2 diabetes | OR: 1.0 [0.95, 1.05] | — | — | age, sex | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000234 | Incident type 2 diabtes defined as fasting glucose >= 7 mmol/L, 2 hour glucose >= 11.1 mmol/L, antidiabetic medication use, or a physician diagnosis of type 2 diabetes | Range = [10.0, 15.0] years | [ ,
37.93 % Male samples |
Mean = 57.4 years Sd = 7.43 years |
African unspecified | — | ARIC, MESA | Partial overlap with discovery GWAS |